Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer

BACKGROUND: Pancreatic cancer (PC) is one of the worst prognoses amongst all malignant diseases. It is therefore of great significance to identify biomarkers with predictive clinical value for the prognosis and recurrence of PC. METHODS: In our study, enzyme-linked immunosorbent assays (ELISA) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qian, Li, Ze, Feng, Honglei, Ren, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112875/
https://www.ncbi.nlm.nih.gov/pubmed/33994808
http://dx.doi.org/10.2147/CMAR.S304719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112875/
https://www.ncbi.nlm.nih.gov/pubmed/33994808
http://dx.doi.org/10.2147/CMAR.S304719

Ejemplares similares